These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7655010)

  • 41. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides.
    Weisel JW
    Biophys J; 1986 Dec; 50(6):1079-93. PubMed ID: 3801570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A two-step fibrinogen--fibrin transition in blood coagulation.
    Blombäck B; Hessel B; Hogg D; Therkildsen L
    Nature; 1978 Oct; 275(5680):501-5. PubMed ID: 692730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 46. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
    Mullin JL; Gorkun OV; Binnie CG; Lord ST
    J Biol Chem; 2000 Aug; 275(33):25239-46. PubMed ID: 10837485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
    Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
    J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrin polymerization and release of fibrinopeptide B by thrombin.
    Hurlet-Jensen A; Cummins HZ; Nossel HL; Liu CY
    Thromb Res; 1982 Aug; 27(4):419-27. PubMed ID: 7147212
    [No Abstract]   [Full Text] [Related]  

  • 50. Interaction of thrombin and fibrinogen and the polymerization of fibrin monomer.
    Scheraga HA
    Ann N Y Acad Sci; 1983 Jun; 408():330-43. PubMed ID: 6575693
    [No Abstract]   [Full Text] [Related]  

  • 51. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
    Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
    Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain.
    Odrljin TM; Shainoff JR; Lawrence SO; Simpson-Haidaris PJ
    Blood; 1996 Sep; 88(6):2050-61. PubMed ID: 8822924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod.
    Shen LL; Hermans J; McDonagh J; McDonagh RP
    Am J Physiol; 1977 Jun; 232(6):H629-33. PubMed ID: 879301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides.
    Chang MC; Wang BR; Huang TF
    Thromb Haemost; 1995 Aug; 74(2):764-9. PubMed ID: 8585019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin).
    Mosesson MW; DiOrio JP; Müller MF; Shainoff JR; Siebenlist KR; Amrani DL; Homandberg GA; Soria J; Soria C; Samama M
    Blood; 1987 Apr; 69(4):1073-81. PubMed ID: 3548843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin-binding domain of fibrin mediates its binding to endothelial cells.
    Odrljin TM; Francis CW; Sporn LA; Bunce LA; Marder VJ; Simpson-Haidaris PJ
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1544-51. PubMed ID: 8977460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM; Mullin JL; Lord ST
    Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin.
    Maurer MC; Peng JL; An SS; Trosset JY; Henschen-Edman A; Scheraga HA
    Biochemistry; 1998 Apr; 37(17):5888-902. PubMed ID: 9558322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.